Back to top
Top
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

All eCQMs associated with: Process measure

Year Type CMS eCQM ID Measure Name
2023 EC CMS177v11 Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment
2024 EC CMS177v12 Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment
2022 EH CMS190v10 Intensive Care Unit Venous Thromboembolism Prophylaxis
2023 EH CMS190v11 Intensive Care Unit Venous Thromboembolism Prophylaxis
2024 EH CMS190v12 Intensive Care Unit Venous Thromboembolism Prophylaxis
2022 EC CMS249v4 Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture
2023 EC CMS249v5 Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture
2024 EC CMS249v6 Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture
2022 EC CMS347v5 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
2023 EC CMS347v6 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
2024 EC CMS347v7 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
2022 EC CMS349v4 HIV Screening
2023 EC CMS349v5 HIV Screening
2024 EC CMS349v6 HIV Screening
2022 EH CMS506v4 Safe Use of Opioids - Concurrent Prescribing
2023 EH CMS506v5 Safe Use of Opioids - Concurrent Prescribing
2024 EH CMS506v6 Safe Use of Opioids - Concurrent Prescribing
2022 EC CMS645v5 Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy
2023 EC CMS645v6 Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy
2024 EC CMS645v7 Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy